Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Pembrolizumab in addition to trastuzumab and chemotherapy for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma – First-line Pembrolizumab (Keytruda; MK-3475) , Trastuzumab (Herceptin; RG-597) Gastric cancer , Gastro-oesophageal junction cancer Gastrointestinal Cancer 2019 View  |  Download
Pembrolizumab in addition to platinum therapy and radiation for unresectable locally advanced head and neck squamous cell carcinoma Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475) Head and neck cancer Head and Neck Cancer 2019 View  |  Download
Pembrolizumab in addition to cisplatin and fluorouracil for recurrent locally advanced or metastatic oesophageal cancer – First-line 5-Fluorouracil , Cisplatin (Platinol) , Pembrolizumab (Keytruda; MK-3475) Oesophageal cancer Head and Neck Cancer 2019 View  |  Download
Pembrolizumab in addition to chemotherapy for perioperative treatment of gastric or gastro-oesophageal junction adenocarcinoma FLOT , Pembrolizumab (Keytruda; MK-3475) Gastric cancer , Gastro-oesophageal junction cancer Gastrointestinal Cancer 2019 View  |  Download
Pegcetacoplan (APL-2) for paroxysmal nocturnal haemoglobinuria Pegcetacoplan (APL-2) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2019 View  |  Download
Palovarotene for flare-ups in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
Palovarotene for episodic and chronic use in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
OTL-200 for Metachromatic Leukodystrophy OTL-200 (GSK-2696274) Metachromatic leukodystrophy (MLD) Endocrine Nutritional and Metabolic Disorders , Genetic Disorders 2019 View  |  Download
Onfekafusp alfa in addition to doxorubicin for advanced or metastatic soft tissue sarcoma – first line Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Onfekafusp alfa (L19-TNF; Fibromun) Soft tissue sarcoma Sarcoma 2019 View  |  Download
Omalizumab for chronic rhinosinusitis with nasal polyps Omalizumab (Xolair) Rhinosinusitis Ear Nose and Throat (ENT) 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications